Return to QS100 Overview

Cardiovascular risk assessment and lipid modification [QS100]

Measuring the use of this guidance

Statement: 5

Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg.

Quality standard measure: Proportion of adults choosing statin therapy for primary prevention of CVD who are prescribed atorvastatin 20 mg.
What was measured: Proportion of patients in Wales between May 2008 and December 2014 prescribed a statin for primary prevention of CVD who were prescribed atorvastatin.
Data collection end: December 2014
Area covered: Wales
Source: Protty Majd B, Lacey Arron, Hayes Jamie, and Freeman Phillip. (2016). Statins for primary prevention in practice: clinical use in Wales and the NICE guideline effect. British journal of clinical pharmacology, 82(3), pp.892-4.

 Return to QS100 Overview